Sin embargo, para obtener resultados ms avanzados, como blanqueamiento de la piel, desintoxicacin del hgado o efectos antienvejecimiento , suelen ser necesarias dosis ms altas administradas por va intravenosa o inyectable , que oscilan entre 600 mg y 2.400 mg por sesin , en funcin del peso corporal y los objetivos del tratamiento
The STEP clinical trials, which tested semaglutide at multiple dose levels, showed that participants lost an average of 15% of their baseline body weight over 68 weekstranslating to roughly 0.25 to 0.75 pounds weekly on average, though results cluster around higher losses during active treatment phases
Their ability to promote weight loss quickly made them popular for treating obesity as well
This is by design, and reflects the necessity of clinical trials to assess clinical impact for a specific therapeutic and indication
They also had unique bacterial compositions (Hu et al., 2019)
Subgroup meta-analyses based on participants kidney function indicated that the salutary effects of SGLT2i on MACE, cardiovascular death or HHF, and a composite kidney outcome (substantial loss of kidney function, end-stage kidney disease or death due to kidney disease) do not significantly differ among subgroups based on eGFR [142, 252]